Biosurfit Company
Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.
%20.jpg)
Last Funding Type:
Series A
Funding Status:
Early Stage Venture
Headquarters:
Lisbon, Lisboa, Portugal
Founded Date:
01.01.2006
Investor Type:
For Profit
Total Funding:
€10M
Technology:
Genetic Test & Molecular Diagnostics
Employee Number:
51-100
Estimated Revenue:
$10M to $50M
Investors Number:
4
Industry:
Deep Diagnostics